BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Ablexis 



San Francisco  California    U.S.A.
Phone: 415-978-2177 Fax: 415-978-1929


SEARCH JOBS


Industry
Biotechnology






 Company News
Ablexis Announces Licensing of the AlivaMab Mouse Technology to Another Major Pharmaceutical Company 7/10/2012 10:21:51 AM    More...
Ablexis Appoints Jake Bauer as Senior Director, Corporate Development and Business Operations 6/15/2011 6:35:37 AM    More...
Ablexis Appoints Sean Stevens, Ph.D., as Vice President, Research 11/18/2010 12:22:09 PM    More...
Ablexis Cuts Deal With Pfizer Inc. (PFE), Four Other Pharmas, For Antibody Drug Discovery Tool in Deal Worth up to $50 Million 10/26/2010 8:04:35 AM    More...
Ablexis Maps Out New Antibody Drug Strategy with $12M From Third Rock Ventures, Pfizer Inc. (PFE) 6/23/2010 7:17:56 AM    More...
Ablexis Appoints R. Scott Greer Chairman of the Board and Richard Hoffman Chief Business Officer 6/22/2010 6:55:35 AM    More...
Ablexis Secures $12 Million in Series A Funding to Engineer and Commercialize Next-Generation Platforms for Antibody Drug Discovery 6/2/2010 6:33:31 AM    More...

//-->